169 related articles for article (PubMed ID: 11497292)
1. Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2001; 21(3B):2021-8. PubMed ID: 11497292
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):65-70. PubMed ID: 11286132
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):71-6. PubMed ID: 11286133
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase expression in childhood astrocytomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(5A):3287-92. PubMed ID: 11062755
[TBL] [Abstract][Full Text] [Related]
6. Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
In Vivo; 2001; 15(2):175-80. PubMed ID: 11317524
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(6B):4585-90. PubMed ID: 11210857
[TBL] [Abstract][Full Text] [Related]
8. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):667-73. PubMed ID: 11212844
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):659-66. PubMed ID: 11212843
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U
Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
16. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
Loo WT; Chen JP; Chow LW; Chou JW
Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
[TBL] [Abstract][Full Text] [Related]
17. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
18. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
19. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
[TBL] [Abstract][Full Text] [Related]
20. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Tang Y; Kesavan P; Nakada MT; Yan L
Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
